The Role of Endothelin in Experimental Cerebral Vasospasm-Reference-Cited by-同舟云学术

The Role of Endothelin in Experimental Cerebral Vasospasm

Published:1995-07-01 Issue:1 Volume:37 Page:78-86
ISSN:0148-396X
Container-title:Neurosurgery
language:en
Short-container-title:

Author:

Roux Sébastien¹,Löftier Bernd-Michael¹,Gray Gillian A.¹,Sprecher Urs¹,Clozel Martine¹,Clozel Jean-Paul¹

Affiliation:

1. Pharma Division, Preclinical Research, F. FHoffmann-La Roche Ltd., Basel, Switzerland

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Surgery

Link

http://academic.oup.com/neurosurgery/article-pdf/37/1/78/24608178/00006123-199507000-00012.pdf

Reference40 articles.

1. Endothelin: A potential modulator of cerebral vasospasm;Asano;Eur J Pharmacol,1990

2. ETB receptors on aortic smooth muscle cells of spontaneously hypertensive rats;Batra;Am J Physiol,1993

3. Nicorandil: Differential contribution of K+ channel opening and guanylate cyclase stimulation to its vasorelaxant effects on various endothelin-1-contracted arterial preparations—Comparisons to aprikalim (RP 52891) and nitroglycerin;Borg;J Pharmacol Exp Ther,1991

4. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist;Clozel;J Pharmacol Exp Ther,1994

5. BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal, but not intravenous injection;Clozel;Life Sci,1993

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Therapeutic Drugs Against Cerebral Vasospasm after Subarachnoid Hemorrhage: A Comprehensive Review of Basic and Clinical Studies;Current Drug Delivery;2017-09-06

2. Effect of Endothelin Receptor Antagonists on Clinically Relevant Outcomes after Experimental Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis;Journal of Cerebral Blood Flow & Metabolism;2015-05-06

3. Endothelin-1-mediated vasoconstriction alters cerebral gene expression in iron homeostasis and eicosanoid metabolism;Brain Research;2014-11

4. Challenges in collecting pharmacokinetic and pharmacodynamic information in an intensive care setting: PK/PD modelling of clazosentan in patients with aneurysmal subarachnoid haemorrhage;European Journal of Clinical Pharmacology;2014-01-24

5. Clinical and angiographical delayed cerebral vasospasms after uncomplicated surgical clipping of unruptured intracranial aneurysms: illustrated review and two case reports added.;Turkish Neurosurgery;2014